Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Par Pharmaceutical Promotes Executives | Contract Pharma
Breaking News

Par Pharmaceutical Promotes Executives

Haughey to serve as president and Campanelli as chief operating officer

Par Pharmaceutical Companies, Inc. has promoted Thomas J. Haughey to the role of president and Paul V. Campanelli to the role of chief operating officer, effective immediately. Both executives will continue to report to Patrick G. LePore, chairman of the board and chief executive officer.

Since joining the company in 2003, Mr. Haughey has served as chief administrative officer, executive vice president, and general counsel and secretary. Mr. Haughey has more than 25 years of accounting, legal and pharmaceutical experience.

In addition to his title as chief operating officer, Mr. Campanelli will retain the title of president of Par Pharmaceutical and assume responsibility for Strativa Pharmaceuticals, the company’s branded division. Mr. Campanelli joined the company in 2001 as senior director, business development and has held positions of increasing responsibilities.

Mr. LePore said, “With the acquisition of Anchen and the pending acquisition of Edict, Par is becoming a larger and more complex organization with three diverse locations and more than 300 additional employees. These new challenges and opportunities require a president and chief operating officer to effectively manage the Company and its subsidiaries. Tom and Paul have been instrumental in Par’s many successes to date, and these expanded titles are a better reflection of their current responsibilities and achievements.”

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters